<?xml version="1.0" encoding="UTF-8"?>
<glossary>
 <title>Abbreviations</title>
 <def-list>
  <def-item>
   <term>1HP</term>
   <def>
    <p>1 month of daily isoniazid and rifapentine</p>
   </def>
  </def-item>
  <def-item>
   <term>3HP</term>
   <def>
    <p>3 months of weekly isoniazid and rifapentine</p>
   </def>
  </def-item>
  <def-item>
   <term>ACTG</term>
   <def>
    <p>AIDS Clinical Trials Group</p>
   </def>
  </def-item>
  <def-item>
   <term>AECID</term>
   <def>
    <p>Agencia Española de Cooperación Internacional para el Desarrollo (Spanish Agency for International Development Corporation</p>
   </def>
  </def-item>
  <def-item>
   <term>AFB</term>
   <def>
    <p>acid-fast bacilli</p>
   </def>
  </def-item>
  <def-item>
   <term>AFD</term>
   <def>
    <p>French Development Agency</p>
   </def>
  </def-item>
  <def-item>
   <term>ART</term>
   <def>
    <p>antiretroviral therapy</p>
   </def>
  </def-item>
  <def-item>
   <term>ATT</term>
   <def>
    <p>antituberculosis therapy</p>
   </def>
  </def-item>
  <def-item>
   <term>CDC</term>
   <def>
    <p>Centers for Disease Control and Prevention</p>
   </def>
  </def-item>
  <def-item>
   <term>CROI</term>
   <def>
    <p>Conference on Retroviruses and Opportunistic Infections</p>
   </def>
  </def-item>
  <def-item>
   <term>DDI</term>
   <def>
    <p>drug–drug interaction</p>
   </def>
  </def-item>
  <def-item>
   <term>DFID</term>
   <def>
    <p>British Department for International Development</p>
   </def>
  </def-item>
  <def-item>
   <term>DOOR</term>
   <def>
    <p>desirability of outcome ranking</p>
   </def>
  </def-item>
  <def-item>
   <term>DR</term>
   <def>
    <p>drug-resistant</p>
   </def>
  </def-item>
  <def-item>
   <term>DS</term>
   <def>
    <p>drug sensitive</p>
   </def>
  </def-item>
  <def-item>
   <term>EDCTP</term>
   <def>
    <p>European &amp; Developing Countries Clinical Trials Partnership</p>
   </def>
  </def-item>
  <def-item>
   <term>FDA</term>
   <def>
    <p>Food and Drug Administration</p>
   </def>
  </def-item>
  <def-item>
   <term>FQ</term>
   <def>
    <p>fluoroquinolone</p>
   </def>
  </def-item>
  <def-item>
   <term>IMPAACT</term>
   <def>
    <p>International Maternal Pediatric Adolescent AIDS Clinical Trials Network</p>
   </def>
  </def-item>
  <def-item>
   <term>ICMR</term>
   <def>
    <p>Indian Council of Medical Research</p>
   </def>
  </def-item>
  <def-item>
   <term>IGRA</term>
   <def>
    <p>interferon gamma release assay</p>
   </def>
  </def-item>
  <def-item>
   <term>IPT</term>
   <def>
    <p>isoniazid preventive therapy</p>
   </def>
  </def-item>
  <def-item>
   <term>IRIS</term>
   <def>
    <p>immune reconstitution inflammatory syndrome</p>
   </def>
  </def-item>
  <def-item>
   <term>IUATLD</term>
   <def>
    <p>International Union Against Tuberculosis and Lung Disease (The Union)</p>
   </def>
  </def-item>
  <def-item>
   <term>LPV</term>
   <def>
    <p>lopinavir</p>
   </def>
  </def-item>
  <def-item>
   <term>LTBI</term>
   <def>
    <p>latent TB infection</p>
   </def>
  </def-item>
  <def-item>
   <term>MDR</term>
   <def>
    <p>multidrug-resistant</p>
   </def>
  </def-item>
  <def-item>
   <term>MRC</term>
   <def>
    <p>Medical Research Council</p>
   </def>
  </def-item>
  <def-item>
   <term>MSF</term>
   <def>
    <p>Médecins Sans Frontières</p>
   </def>
  </def-item>
  <def-item>
   <term>NACO</term>
   <def>
    <p>National AIDS Control Organization</p>
   </def>
  </def-item>
  <def-item>
   <term>NIAID</term>
   <def>
    <p>National Institute of Allergy and Infectious Diseases</p>
   </def>
  </def-item>
  <def-item>
   <term>NICHD</term>
   <def>
    <p>Eunice Kennedy Shriver National Institute of Child Health and Human Development</p>
   </def>
  </def-item>
  <def-item>
   <term>NIH</term>
   <def>
    <p>National Institutes of Health</p>
   </def>
  </def-item>
  <def-item>
   <term>NIHR</term>
   <def>
    <p>National Institute for Health Research</p>
   </def>
  </def-item>
  <def-item>
   <term>NRTI</term>
   <def>
    <p>nucleoside reverse transcriptase inhibitor</p>
   </def>
  </def-item>
  <def-item>
   <term>NNRTI</term>
   <def>
    <p>nonnucleoside reverse transcriptase inhibitor</p>
   </def>
  </def-item>
  <def-item>
   <term>NVP</term>
   <def>
    <p>nevirapine</p>
   </def>
  </def-item>
  <def-item>
   <term>OBR</term>
   <def>
    <p>optimized background regimen</p>
   </def>
  </def-item>
  <def-item>
   <term>PD</term>
   <def>
    <p>pharmacodynamics</p>
   </def>
  </def-item>
  <def-item>
   <term>PK</term>
   <def>
    <p>pharmacokinetics</p>
   </def>
  </def-item>
  <def-item>
   <term>PREGLAC</term>
   <def>
    <p>US Federal Task Force on Research Specific to Pregnant Women and Lactating Women</p>
   </def>
  </def-item>
  <def-item>
   <term>RADAR</term>
   <def>
    <p>response adjusted for duration of antibiotic risk</p>
   </def>
  </def-item>
  <def-item>
   <term>RR</term>
   <def>
    <p>rifampicin resistant</p>
   </def>
  </def-item>
  <def-item>
   <term>SDC</term>
   <def>
    <p>Swiss Agency for Development and Cooperation</p>
   </def>
  </def-item>
  <def-item>
   <term>TB</term>
   <def>
    <p>tuberculosis</p>
   </def>
  </def-item>
  <def-item>
   <term>TBD</term>
   <def>
    <p>to be determined</p>
   </def>
  </def-item>
  <def-item>
   <term>TBTC</term>
   <def>
    <p>Tuberculosis Trials Consortium</p>
   </def>
  </def-item>
  <def-item>
   <term>THINK</term>
   <def>
    <p>TB&amp;HIV Investigative Network</p>
   </def>
  </def-item>
  <def-item>
   <term>TST+</term>
   <def>
    <p>tuberculin skin test positive</p>
   </def>
  </def-item>
  <def-item>
   <term>USAID</term>
   <def>
    <p>United States Agency for International Development</p>
   </def>
  </def-item>
  <def-item>
   <term>WHO</term>
   <def>
    <p>World Health Organization</p>
   </def>
  </def-item>
  <def-item>
   <term>XDR</term>
   <def>
    <p>extremely drug-resistant</p>
   </def>
  </def-item>
 </def-list>
</glossary>
